RGNX Competitors & Alternatives
Compare Regenxbio Inc with similar stocks in the same industry
Biotechnology
RGNX
Main Stock$9.96
Tradestie Score
50
Market Cap
$493.52M
Revenue Growth
-0.9%
Analyst Upside
+143.7%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.11
|
$688.47M | - | 45 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.06
|
$670.30M | - | 54 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.88
|
$665.30M | - | 58 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.84
|
$626.91M | - | 51 | Compare |
|
SVRA
Savara Inc.
|
$5.33
|
$611.84M | - | 58 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
MPLT
MPLT
|
$12.55
|
$590.40M | - | 51 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.17
|
$552.46M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$5.69
|
$541.60M | - | 53 | Compare |
More RGNX Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry